Henry County

Procurement and Suspension and Debarment Finding Number: 2023-001 Assistance Listing Number and Title: AL # 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases Federal Award Identification Number / Year: 03510012EO0323 / 2023 Federal Agency: U.S. Department of Health and Human Services Compliance Requirement: Procurement and Suspension and Debarment Pass-Through Entity: Ohio Department of Health Repeat Finding from Prior Audit? No Noncompliance and Material Weakness 2 CFR §300 gives regulatory effect to the Department of Health and Human Services for 2 CFR §200 which sets forth the Procurement and Audit requirements for Federal Awards. 2 CFR 180.305 states that Non-Federal entities are prohibited from entering into a covered transaction with parties that are suspended or debarred or whose principals are suspended or debarred, unless the Federal agency responsible for the transaction grants an exception under 2 CFR § 180.135. 2 CFR 180.200 identifies “covered transactions” as nonprocurement or procurement transactions at the primary tier, between a Federal agency and a person; or at the lower tier, between a participant in a covered transaction and another person. Procurement contracts for goods and services awarded under a nonprocurement transaction (e.g., grant or cooperative agreement) are covered transactions if the contracts are expected to equal or exceed $25,000 or meet certain other specified criteria outlined in 2 CFR § 180.220. All nonprocurement transactions (i.e., subawards to subrecipients), irrespective of award amount, are considered covered transactions, unless exempt by 2 CFR § 180.215. When a non-Federal entity enters into a covered transaction, the non-Federal entity must verify that the entity is not suspended or debarred or otherwise excluded. This verification may be accomplished by checking SAM exclusions (https://sam.gov/content/home); collecting a certification from the entity, or adding a clause or condition to the covered transactions with that entity. The District did not have the proper internal controls in place to verify that all entities, with whom the District had entered into covered transactions, had not been suspended or debarred. During testing of nonpayroll transactions for the Epidemiology and Laboratory Capacity for Infectious Diseases (AL# 93.323) program, we noted one instance in which the program had a payment to a vendor of more than $25,000 and there was no evidence the District checked the SAM exclusions, collected a certification from the entity, or added a clause or condition to the covered transaction with the vendor. Due to the deficient internal control structure, the required verification was not completed for the covered transaction in the Epidemiology and Laboratory Capacity for Infectious Diseases (AL# 93.323) program during 2023. Failing to have the appropriate controls in place may result in vendors receiving federal funds that are suspended or debarred. Prior to contracting with vendors that will be paid with federal funds, the District should verify the vendor is not suspended or debarred by checking the SAM exclusions, collecting a certification from the vendor, or adding a clause or condition to the covered transaction with the vendor.

GSA_MIGRATION